Tenet Healthcare to sell 3 South Carolina hospitals to Novant Health
By Steve Gelsi
Tenet will retain its ambulatory facilities unit in the state.
Tenet Healthcare Corp. said Friday it agreed to sell three hospitals and related operations in South Carolina for about $2.4 billion in cash to Novant Health Inc.
The deal's after-tax proceeds are about $1.75 billion.
Tenet Health expects to close the transaction in the first quarter. The transaction includes Coastal Carolina Hospital, Hilton Head Hospital and East Cooper Medical Center.
Tenet Healthcare will not sell its ambulatory facilities operated by United Surgical Partners Int. in the markets served by the three hospitals. Those hospitals generated $552 million in revenue for the last 12 months ending Sept. 30.
Privately held Novant Health is based in Winston-Salem, N.C. as a network of hospitals, physician clinics and outpatient facilities with more than 1,900 physicians and 36,000 employees. The company's portfolio includes 800 locations, including 16 hospitals.
Tenet Healthcare's stock is up 19.2% in 2023, compared with a 17.4% rise by the S&P 500 SPX. Tenet Healthcare's (THC) stock was up by 11% in morning trading.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-17-23 0946ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
5 Ultracheap Stocks to Buy With the Best Returns on Investment
-
Broadcom Earnings: AI Sales Growth Accelerates
-
Oracle Earnings: IaaS Signings More Than Make Up for Miss
-
This Undervalued Stock Is a Buy After Its Dividend Increase
-
After Earnings, Is Nio Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Lululemon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
The Most Attractive Investment Opportunities in Oil & Gas